Contact
Disclaimer
Privacy Policy
Site Map
Japanese
English
Open Menu
HOME
About
Management Strategy
Business Model
CEO Message
Corporate Philosophy
Management
Board of Directors
Patent
Company Profile
Corporate History
Partnering
US Career
Pipeline
Outline of Our Pipeline
Telomelysin (OBP-301)
OBP-601(Censavudine)
OBP-2011
OBP-702
OBP-801
TelomeScan
(OBP-401 , OBP-1101)
Patent
Publications
Investors
IR Information
IR News
Our Philosophy
Financial Statements
Presentation Materials
Stock Information
Stock Quotes
IR Inquiry
IR Disclaimer
Our Pipeline Overview
News & Event
Contact
Japanese
Home
About
Management Strategy
Business Model
CEO Message
Corporate Philosophy
Management
Board of Directors
Company Profile
Corporate History
Partnering
US Career
Pipeline
Outline of Our Pipeline
Telomelysin (OBP-301)
OBP-601 (Censavudine)
OBP-2011
OBP-702
OBP-801
TelomeScan (OBP-401 , OBP-1101)
Patent
Publications
Investors
IR Information
IR News
Our Philosophy
Our Pipeline Overview
Financial Statements
Presentation Materials
Stock Information
Stock Quotes
IR Inquiry
IR Disclaimer
News & Event
Top
> News & Event
News & Event